Sygnature Discovery are sponsoring OBN’s PharmaTuesday industry debate on Pharma Externalisation on April 14th 2015
OBN PharmaTuesday – Should Pharma Externalization go to 100%?
Chesterford Research Park, Little Chesterford, CB10 1XL
Tuesday, 14 April 2015 from 18:00 to 21:30
Senior speakers from all sides of the industry will debate the contentious question whether biotech really can afford for big pharma to externalise R&D completely.
Paul Clewlow, Senior Vice President – Business Development at Sygnature Discovery who are sponsoring the debate will make an address and then hand over to the panel:
Simon Hirst, CEO, Sygnature Discovery
Rob Pinnock, Director, Business Development & Licensing MRL, MSD
Georg Buchner, Licensing Director, Europe, Amgen
Richard Mason, CEO, X01
Ann Connolly, Senior Director New Ventures, Johnson & Johnson Innovation
Ian Moules, Senior Director, Search & Evaluation, Global Licensing & Business Development, Takeda Pharmaceuticals